Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2010
06/01/2010US7727524 Low sodium liquid seasoning with anti-hypertensive activity
06/01/2010US7727519 Method for treating hepatitis C virus with omega interferon
06/01/2010US7727466 test film made of water soluble two polymers, one having high molecular weight and the other having low molecular weight such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose; for detecting chorionic gonadotropin, glucose, prostate specific antigen, metabolites; pesticides; or toxin; monolayer
06/01/2010US7727275 Drug-delivery endovascular stent and method of forming the same
06/01/2010US7727223 Drug delivery technology
06/01/2010US7727204 Device for dosing a product that is intended to be applied to the skin
06/01/2010US7727186 Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
06/01/2010CA2525867C Natural compounds and their derivatives for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
06/01/2010CA2509775C Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
06/01/2010CA2440699C Compounds for treating inflammatory diseases
06/01/2010CA2431888C Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
06/01/2010CA2428817C Copolyvidone-containing preparation
06/01/2010CA2403711C Methods of producing a terminally sterilized topical patch preparation
06/01/2010CA2366601C Non-stinging coating composition
06/01/2010CA2361552C Drug for alleviating migraine
06/01/2010CA2353363C Starch- and lactose-based pellets
06/01/2010CA2336879C Sustained-release formulations comprising peptides, polypeptides, proteins or nucleic acids as active ingredients
06/01/2010CA2256592C Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent
06/01/2010CA2176249C Aerosol drug formulations for use with non-cfc propellants
05/2010
05/27/2010WO2010060110A1 Polyvalent rna-nanoparticle compositions
05/27/2010WO2010060068A1 Liposome drug carriers with ph-sensitivity
05/27/2010WO2010059963A2 Preparation and methodology of silk fibroin nanoparticles
05/27/2010WO2010059883A1 Degradable hydrogel compositions and methods
05/27/2010WO2010059812A1 Surface-modified metal phosphate nanoparticles
05/27/2010WO2010059787A1 Therapeutic protein formulations
05/27/2010WO2010059667A1 Pharmaceutical composition of a potent hcv inhibitor for oral administration
05/27/2010WO2010059534A2 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
05/27/2010WO2010059506A1 Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient
05/27/2010WO2010059504A1 Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
05/27/2010WO2010059259A1 Process for recovering florfenicol from pharmaceutical compositions
05/27/2010WO2010059253A2 Methods and compositions for localized agent delivery
05/27/2010WO2010059244A2 Method for reducing thrombocytopenia and thrombocytopenia-associated mortality
05/27/2010WO2010059135A1 Anti-cancer microparticle
05/27/2010WO2010059038A2 Wet granulation of tenofovir, emtricitabine and efavirenz
05/27/2010WO2010058924A2 Fast dissolving oral tablets and method for production thereof
05/27/2010WO2010058853A1 Ceramide dispersion, and process for producing same
05/27/2010WO2010058844A1 Adhesive material containing 5-methyl-1-phenyl-2-(1h)-pyridone
05/27/2010WO2010058669A1 Novel prostaglandin e1 derivative, and nanoparticle having same encapsulated therein
05/27/2010WO2010058349A1 Pharmaceutical composition for topical application
05/27/2010WO2010058297A2 The use of ph-sensitive, acid-stable metal-binding nanoparticles
05/27/2010WO2010058218A1 Gum compositions
05/27/2010WO2010058106A1 Novel form of administering osteogenic protein complexes
05/27/2010WO2010058104A2 Pharmaceutical compositions containing inulin as granulation carrier
05/27/2010WO2010058070A1 Intravaginal delivery system and process for manufacturing it
05/27/2010WO2010057928A1 Aerosol formulation for the inhalation of beta agonists
05/27/2010WO2010057927A1 Aerosol formulation for the inhalation of beta agonists
05/27/2010WO2010057870A1 Prolonged release formulations comprising an 2 -oxo- 1 -pyrrolidine derivative
05/27/2010WO2010057869A1 Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate
05/27/2010WO2010057594A1 Drug delivery system
05/27/2010WO2010057449A2 A solid pharmaceutical composition with atorvastatin and telmisartan as the active substances
05/27/2010WO2010057447A1 Single-time vaccines
05/27/2010WO2010057442A1 A optical isomer of benzene propanoic acid and its medicinal use
05/27/2010WO2010057317A1 Liposomal composition for convection-enhanced delivery to the central nervous centre
05/27/2010WO2010057295A1 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
05/27/2010WO2010028843A4 Tablets for subsequent nanoparticle suspension filling using ultrasound
05/27/2010WO2010028826A3 A method for the production of bioadhesive compact matrices
05/27/2010WO2010025322A9 Magnetic nanodelivery of therapeutic agents across the blood brain barrier
05/27/2010WO2010022193A3 Hot-melt extrusion of modified release multi-particulates
05/27/2010WO2010019718A3 Carrier nanoparticles and related compositions, methods and systems
05/27/2010WO2010005480A9 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
05/27/2010WO2010003078A3 Melt granulation process
05/27/2010WO2010003009A3 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors
05/27/2010WO2009140649A3 Rab3b for the treatment and prevention of parkinson's disease
05/27/2010WO2009137648A8 Multilayer proton pump inhibitor tablets
05/27/2010WO2009129387A3 Cationic lipids and uses thereof
05/27/2010WO2009061003A3 Nucleic acid complex and nucleic acid delivery composition
05/27/2010WO2006133835A8 Oral solid pharmaceutical formulation of the tubulin inhibitor indibulin
05/27/2010US20100129496 Nutritional formulations
05/27/2010US20100129461 Process for Dispersing Amino Acids
05/27/2010US20100129460 Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics
05/27/2010US20100129459 biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof
05/27/2010US20100129458 Compositions and methods for inhibiting reproduction in tadpole shrimp
05/27/2010US20100129457 Nanodiamond Enhanced Drugs
05/27/2010US20100129456 Sustained-release nanoparticle containing low-molecular-weight drug with negatively charged group
05/27/2010US20100129455 Nanoparticle-dispersed fine glass beads having a cavity therein, and method of producing the same
05/27/2010US20100129453 Emulsions comprising rubber arabicum
05/27/2010US20100129452 Cellulose derivative and method for production thereof
05/27/2010US20100129451 Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery
05/27/2010US20100129450 Electrospun Cell Matrices
05/27/2010US20100129448 Topical hydrogel composition
05/27/2010US20100129447 Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
05/27/2010US20100129446 Solid dosage forms comprising an enteric coating with accelerated drug release
05/27/2010US20100129445 Gastroretentive system comprising an alginate body
05/27/2010US20100129444 Novel Pharmaceutical Formulations of Modafinil
05/27/2010US20100129443 Non-abusable pharmaceutical composition comprising opioids
05/27/2010US20100129442 Oral Multi-Functional Pharmaceutical Capsule Preparations Of Proton Pump Inhibitors
05/27/2010US20100129441 Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
05/27/2010US20100129440 Embryonic-like stem cells derived from adult human peripheral blood and methods of use
05/27/2010US20100129439 Adjuvant Incorporation in Immunonanotherapeutics
05/27/2010US20100129438 Methods and Compositions for the Treatment and Prevention of HIV Infection Using TRIM5ALPHA
05/27/2010US20100129437 Targeted intracellular delivery of antiviral agents
05/27/2010US20100129436 Subtances for the protection of cells and/or tissues
05/27/2010US20100129435 Methods and compositions for treatment of ocular neovascularization and neural injury
05/27/2010US20100129434 Compositions and methods for the treatment of mucormycosis and other fungal diseases
05/27/2010US20100129433 Proteoliposome, Production Method Thereof, and Biochip
05/27/2010US20100129432 Microorganism-killing combination
05/27/2010US20100129431 Idebenone composition for the treatment of neurological disorders
05/27/2010US20100129430 Liposome drug carriers with ph-sensitivity
05/27/2010US20100129429 Inhibition of autophagy genes in cancer chemotherapy
05/27/2010US20100129428 Supra molecular construct for delivery of interferon to a mammal
1 ... 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 ... 2991